Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary ovarian failure in which the cause of the disease is a mutation in the STAG3 gene.
Features include always present findings: Premature ovarian insufficiency, Elevated circulating luteinizing hormone level, Elevated circulating follicle stimulating hormone level, and Streak ovary and others; and very common findings: Primary amenorrhea. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 2 | Elevated circulating luteinizing hormone level, Elevated circulating follicle stimulating hormone level |
STAG3 function has not been fully characterized.
Premature ovarian failure 8 is associated with mutations in the STAG3 gene on chromosome 7.
Genetic testing for STAG3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for premature ovarian failure 8 has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 1 very common feature.
No clinical trials have been registered for premature ovarian failure 8.
128 publications have been identified in PubMed for premature ovarian failure 8. Research spans Epidemiology / Natural History (38%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 49 | 38% |
Data assembled from 5 of 12 sources · Last updated Nov 2, 2026, 8:19 PM UTC
Online Mendelian Inheritance in Man
Hormones | 1 | Primary amenorrhea |
Laboratory research
32 |
25% |
Research summaries | 17 | 13% |
Clinical study results | 10 | 8% |
Patient case studies | 8 | 6% |
New treatment approaches | 6 | 5% |
Testing and diagnosis research | 5 | 4% |
Other research | 1 | 1% |
Liu X (2027). [PMID: 42604715](https://pubmed.ncbi.nlm.nih.gov/42604715/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Balachandren N (2026). [PMID: 42497321](https://pubmed.ncbi.nlm.nih.gov/42497321/). *Hum Reprod Update*. [Epidemiology / Natural History]
Su H (2026). [PMID: 41940375](https://pubmed.ncbi.nlm.nih.gov/41940375/). *Hum Reprod Open*. [Review / Meta-Analysis]
Derhab M (2026). [PMID: 41474091](https://pubmed.ncbi.nlm.nih.gov/41474091/). *Mov Disord Clin Pract*. [Review / Meta-Analysis]
Lu TF (2026). [PMID: 42468866](https://pubmed.ncbi.nlm.nih.gov/42468866/). *Am J Obstet Gynecol*. [Clinical Trial Publication]
Usman M (2026). [PMID: 42445973](https://pubmed.ncbi.nlm.nih.gov/42445973/). *Menopause*. [Epidemiology / Natural History]
Langhe R (2026). [PMID: 42475881](https://pubmed.ncbi.nlm.nih.gov/42475881/). *Maturitas*. [Review / Meta-Analysis]
Akgün M (2026). [PMID: 42056651](https://pubmed.ncbi.nlm.nih.gov/42056651/). *Reprod Sci*. [Gene Therapy / Novel Therapeutics]
Koyun Alvuroğlu E (2026). [PMID: 42098761](https://pubmed.ncbi.nlm.nih.gov/42098761/). *BMC Womens Health*. [Basic Science / Preclinical]
Zhang M (2026). [PMID: 42650159](https://pubmed.ncbi.nlm.nih.gov/42650159/). *Genes (Basel)*. [Basic Science / Preclinical]